Purpose The present contribution analyses long-term data regarding oncological, functional, and quality of life aspects of patients subjected to cystectomy due to malignancy with subsequent orthotopic bladder substitution. Methods A literature search was conducted to review literature published from 1887 until today. Oncological aspects, special considerations on female patients, quality of life, geriatric patients, and impact of minimally invasive surgery were also addressed and discussed. Results After more than three decades, orthotopic bladder substitution subsequent to radical cystectomy has stood the test of time by providing adequate long-term survival and low local recurrence rates. Compared to radical cystectomy, neither radiation nor chemotherapy, nor a combination of both, offer similar long-term results. Orthotopic bladder substitution does not compromise oncological outcome and can be performed with excellent results regarding functional and quality of life issues.
Introduction
Bardenheuer from Cologne (male cystectomy) and Pawlik from Prague (female cystectomy) were the first surgeons who performed and documented cystectomy in the late nineteenth century [1, 2] . In the following decades, surgeons were struggling with a tremendously high intra and postoperative mortality associated with this surgical procedure, mainly due to problems with the procedure itself as well as the subsequent urinary diversion. In 1939, Hinman [3] still reported a perioperative mortality rate of around 35%. Due to refinements of surgical techniques as well as the improvement of anesthesia and the introduction of sufficient antibiotics into clinical routine, functional outcome improved and perioperative mortality associated with cystectomy decreased to around 1-2% at the end of the last century. Accordingly, postoperative morbidity after cystectomy in both male and female patients regardless of the type of urinary diversion could be reduced to around 14% in recent years [4, 5] . An additional development was the establishment of lymphadenectomy as an integral part of the procedure. First, considered as a staging approach for the detection or exclusion of lymphatic spread into the regional lymph nodes, it was identified to cure patients with minimal lymph node involvement (N1) from the disease or at least to significantly improve the clinical course of the disease [4] . In the meantime, the number of removed lymph nodes has become an independent prognostic factor for local pelvic control as well as survival [6] . Another important aspect, which was repeatedly and frequently discussed in addition to the technique and extent of bladder removal itself, was the most beneficial type of urinary diversion. Aspects addressed in this context included the issue of optimal upper tract protection, as discussed in early papers, as well as the formation of a low pressure or continent reservoir, either utilizing colorectal or small bowel segments for orthotopic neobladder substitution both in male and in female patients [7] .
After improvement of oncological and functional results, the discussion included quality of life aspects such as maintenance of erectile function and sexual activity. In recent years, several authors have evaluated and identified the exact anatomical localization of autonomic nerves within the pelvis. Approaches were described to preserve these structures and thereby increase the probability of an acceptable postoperative sexual life in male as well as in female patients. Meticulous dissection of the urethra and preservation of the sphincteric complex were of uppermost importance for postoperative voiding function [8] . It has also been suggested that, for patients subjected to an orthotopic bladder substitution, the preservation of autonomic nerves substantially contributes to maintenance of continence and intact voiding function. Orthotopic neobladders are the preferred type of urinary diversion in the majority of centers with large experience in this kind of surgery. However, a recent WHO consensus conference on bladder cancer treatment has shown considerable regional differences with regard to the type as well as the modifications of urinary diversion [9] .
The present contribution analyses long-term data regarding oncological, functional, and quality of life aspects of patients subjected to cystectomy due to malignancy with subsequent orthotopic bladder substitution Table 1 .
Methods
A literature search was conducted to review literature published from 1887 until today. Oncological aspects, special considerations on female patients, quality of life, sexual function, geriatric patients, and aspects on minimally invasive surgery were also addressed.
Results

Oncological aspects
Without treatment, about 85% of patients with muscleinvasive bladder cancer will die within the first 2 years following initial diagnosis [10] . It has become clear over the last decades that radical cystectomy is the standard of care in high-grade invasive bladder tumors, because it provides the best survival as well as the lowest recurrence rates in these patients [9, [11] [12] [13] [14] . Several oncological and technical aspects, however, such as the necessary extent of lymphadenectomy, its diagnostic and/or therapeutic potential, the type of urinary diversion (e.g., ileal conduit versus orthotopic neobladder substitution), and the impact of urethral preservation on the likelihood of urethral or local recurrences following radical cystectomy are still under discussion.
Prostate and seminal vessel sparing cystectomy appears to be an attractive alternative to standard total cystoprostatectomy concerning sexual function and fertility. However, these advantages come at a price, i.e., a 10-15% higher oncological failure rate [15] .
Variables determining the clinical prognosis of muscle-invasive bladder cancer Several investigations have described tumor and patients' characteristics, thereby revealing possible parameters for the clinical prognosis of patients undergoing cystectomy for muscle-invasive bladder cancer. As initially demonstrated by Lerner et al. [16] and repeatedly confirmed thereafter, [17, 18] here is a clear correlation between patients' long-term survival and local tumor stage. This correlation depends on the presence of extravesical extension A 5-year disease-specific survival of 46-57% was reported for patients with bladder cancer limited to the bladder wall (BpT2b) [16] . In contrast, the long-term survival rate for locally further advanced tumors (C pT3) decreased to 18-30%. Lymphogenic metastatic spread already present at the time of surgery may play a major role. The N-category or, more detailed, the number of positive lymph nodes was identified as an additional parameter of prognostic relevance. The question whether the number of removed nodes increases the likelihood of detecting occult nodal metastases remains a controversially discussed issue. Whereas Herr [19] indicated the correlation of the probability of detecting lymph node metastases with the total number of removed nodes, Abdel-Latif et al. [20] as well as Leissner et al. [21] were not able to confirm such a correlation. The 5-year disease-specific survival of patients subjected to radical cystectomy was reported to range between 7 and 32% in the case of intrapelvic lymph node metastases. For organ-confined bladder tumors, Vieweg et al. [17] observed no survival difference between N0 versus N1 cases. The latter authors described a deteriorated clinical prognosis only in N1 versus N3 patients, whereas Lerner et al. [16] and Mills et al. [22] indicated such a correlation for N1/N2 versus N3 patients (B5 versus [5 lymph nodes affected by metastatic disease). The 5-year survival rate of N1/N2 patients almost doubled compared to that of patients with N3 disease (35% versus 17%). Utilizing a cut-off of 4 or fewer versus 5 or more lymph nodes, the number of positive nodes could not be confirmed as an independent prognostic variable during multivariate statistical analysis [19, 22] . In contrast, Stein et al. [18] indicated the number of involved lymph nodes with a cut-off of 8 lymph nodes as a parameter independently predicting the clinical outcome of an individual patient. The issue of individual differences in the number of (normal) pelvic lymph nodes has not thoroughly been addressed in these studies [4, 15, 16, 18, 20] .
Herr [19] suggested the ratio between negative nodes and lymph nodes harboring metastases (B20%/ [20%) to predict the patients' clinical prognosis most appropriately. The 5-year survival in patients with N? disease and a lymph node density of \20% was 64%, which is significantly higher than the 8% 5 years survival for the same pathological group of patients with a lymph node density of [20%. Recognizing the former data, it seems to be certain that patients with organ-confined bladder cancer only harboring N1 disease have a more favorable clinical prognosis which approximates that of patients with no detectable lymph node metastases. In contrast, the long-term survival rate of N3 patients is almost uniformly lower. Whether the cut-off in the current TNM classification system that discriminates between N2 and N3 patients is appropriate to reflect a clinical prognosis that is supposed to diverge between both groups cannot be definitely answered at present and remains, therefore, to be clarified in larger prospective trials.
Distant and local failure following radical cystectomy depending on type of urinary diversion Overall, the recurrence rate of high-grade, invasive TCC, irrespective of urinary diversion ranges from 27 to 43% in larger series. Eighty-six percent of all recurrences occur within 36 months following surgery, with an average recurrence-free survival of 12 months [4] . However, late recurrences following an interval of more than 5 years have also been reported, thereby indicating the need for a lifelong follow-up.
Second primary tumors of the urethra are rare, and postoperative local recurrences are reported in 5-9% [24] .
Studer et al. [23] reported urethral recurrences in 5% of patients (442 men and 40 women) following cystectomy and orthotopic bladder substitution with an average time to recurrence of 14 months (range 3-158). Secondary urethrectomy was performed in 5 of 482 (1%) patients and a conservative treatment was attempted in 13 cases, 2 of them requiring urethrectomy thereafter. For the whole cohort of neobladder patients suffering from urethral tumor recurrence, the median overall survival decreased to 38 months and 14 patients (2.9%) died from systemic tumor progression.
In a retrospective series by Stein [24] with 768 men subjected to radical cystectomy, irrespective of urinary diversion, the overall urethral recurrence rate was 6%. In a multivariate statistical analysis, prostatic involvement by the primary tumor as well as the formation of a cutaneous urinary diversion were identified to be independently associated with an increased risk for the development of urethral recurrence. The calculated risk of urethral recurrence was 5 versus 9% for patients subjected to an orthotopic versus cutaneous urinary diversion. This difference (12 and 18% versus 5%) was also apparent for TCC patients with superficial, invasive, and without prostate tumor involvement. It has been speculated that a protective effect of urine in contact with the urethra, a reduction of bacterial cancer effects or a selection bias could be reasons for the more favorable outcome in neobladder patients.
The hypothesis that female patients harbor an increased risk for the development of urethral recurrences and should therefore undergo urethrectomy as an integral part of
cystectomy was abandoned more than a decade ago. The incidence of urethral recurrence in women subjected to orthotopic neobladder substitution is inevitably low and predictive [25] . In 841 female patients followed for more than 20 years, the urethral recurrence rate was 2% and dependent on the location of the primary tumor in the bladder, thus confirming the safety of an orthotopic bladder replacement in women. In a series reported by Hautmann [26] that included 643 male and female patients, local pelvic recurrences were observed in 10% of cases. Voiding function in these patients was compromised in only 2% of cases. Treatment of the outlet obstruction due to local recurrence was intermittent self-catheterization, chemotherapy, and/or resection. The authors concluded that even when local recurrence develops in the majority of cases functional aspects following neobladder creation are not deteriorated.
Entero-enteral and entero-reservoir fistulas due to preoperative radiotherapy or local tumor recurrence have been described to affect up to 2% of patients [23, 27] .
In conclusion, the development of a functional deficit possibly caused by local tumor recurrence following orthotopic bladder replacement should not influence the decision toward the construction of this type of urinary diversion.
In contemporary series, upper tract recurrences in patients with urinary diversion due to TCC were demonstrated to occur in 2.4-17% of patients after an average time interval between 8 and 69 months in most series, but upper tract recurrences more than 10 years after cystectomy have been observed [28] . In a series of 1,069 patients undergoing cystectomy for TCC, 2.5% of all patients were diagnosed with upper tract recurrence, median survival was 1.7 years (range 0.2-8.8) [29] .
Female patients
Removing the bladder neck and a small portion of the adjacent urethra will not compromise oncological outcome in the majority of women with bladder cancer and can be satisfactorily used for orthotopic reconstruction of the lower urinary tract.
Studies involving 230 patients explicitly examining urethral recurrence found an isolated urethral recurrence in 1.4-4.3% of patients after a mean follow-up of 36-50 months [50, 51] .
Diurnal and nocturnal continence rates ranging from 82 to 95% and from 72 to 86%, respectively, [5, 52] were comparable to male patients. Hautmann et al. reported a urinary retention of 50% in 116 female patients after a 5-year follow-up, whereas Studer et al. reported a 25% retention rate [24] and Stenzl et al. [5] a 15% intermittent self-catheterization rate after a follow-up of up to 5 years.
Upper urinary tract function and ureterointestinal anastomosis
Ureteroileal stenosis was reported to occur in 2.7% of patients with an afferent tubular segment [23] and in 3.8% of cases with a serosa-lined extramural tunnel technique [30] . Meticulous surgery [31] and anatomical considerations during the procedure are important for good functional results [32] . For different types of afferent anastomosis, long-term maintenance of upper tract function in bladder substitution was demonstrated for the vast majority of patients. When a tubular segment was selected for ureteral anastomosis, rising serum creatinine levels were observed in 3.8% of cases after a 5-years follow-up [23] . After a follow-up of 38 ± 25 months, renal function was demonstrated to be preserved in 96.2% of patients subjected to a serosa-lined extramural tunnel technique [30] .
A low pressure construction of the pouch, a presumably sterile urine, and the possibility of stenosis at the ureteral implantation site served as arguments against a valve-like anti-reflux implantation technique. On the other hand, a potential outlet obstruction with the need of self-catheterization and a higher pressure during pouch evacuation, both being associated with an increased risk for reflux into the upper urinary tract and a possible impairment of upper urinary tract function, have been repeatedly addressed as arguments for reflux protection.
Metabolic changes
The utilization of small bowel for urinary diversion interferes with the physiological renal acid and salt regulation. Meticulous monitoring, careful electrolyte balance as well as sufficient hydration within the first postoperative time period help to avoid dehydration and electrolyte depletion [33] . Osteoporosis and osteomalacia might theoretically develop from a persistent hypokalemic, hyperchloremic acidosis. A transient acidosis developing postoperatively is common and can usually be controlled by oral administration of sodium bicarbonate. Within 4 years of the operation, the reabsorption of metabolic substances of intestinal reservoirs and therefore the extent of metabolic problems associated with neobladder substitution are decreasing significantly [34] .
In a recent investigation by Studer et al., abnormal bone density could not be observed in patients during a followup of 10-15 years. In larger series including 314 patients where terminal ileum was used to substitute the urinary tract, decreased vitamin B12 levels required a substitution in 5% of cases [23] . It is therefore suggested that surgical exclusion of the terminal ileum necessitates regular checking and at times substitution of vitamin B12 after a follow-up of more than 5 years.
Continence and retention
By using detubularized ileal segments for a low pressure bladder substitution with a filling capacity of usually 400-500 ml, continence is mainly achieved by the preservation of the urethral sphincter and its innervation.
After a minimum follow-up of one year, day-time continence could be achieved in 88-95% of male and female patients in recent series [5, 35, 36] . In contrast, ranging from 66 to 93%-depending on definition and management of the patients-night-time continence was reported to be lower [11, 23, 27, 37] . Over time, overall continence was reported to decrease, slightly, a phenomenon which might be due to increasing age and its sequelae, i.e., a decreased muscle tone and decreased volume of the external rhabdosphincter [11, 23, 28, 40] .
Nerve-sparing surgical approaches seem to improve continence following orthotopic neobladder substitution both in male and in female patients [44] . El-Bahnasawy et al. demonstrated a significantly longer functional urethral length and a higher maximal urethral pressure in a cohort of patients undergoing nerve preservation when compared to a non-nerve-sparing control group, hereby supporting a nerve-sparing approach during radical cystectomy [41] .
Additionally, Kessler et al. [42] indicated a correlation between nerve sparing, patients' age (\65 versus[65 years), and the maintenance of continence.
Overall, residual urine volumes of [100 ml were observed in 22% of all neobladder patients (men and women) [23] . In the same series urethral anastomotic strictures occurred in 3.7% of all patients. Seven percent of patients had an occluding protrusion of the ileal bladder mucosa over the neobladder outlet termed ileal valve [43] . An additional 1.7% of patients presented with recurrent prostate adenoma presumably due to subtotal resection of the prostate. The majority of patients with an increased outlet pressure due to subvesical obstructive changes were treated endoscopically, whereas 2% remained with an indwelling catheter and 2.9% were instructed to perform intermittent clean self-catheterization [23] . Hautmann reported transient or permanent retention for 11-12% of both male and female patients [26] . Abol-Enein found an intravesical obstruction in 11 patients in a series of 344 evaluated male patients with a mean follow-up of 38 months. In a multicenter study, urinary retention of 15% in 101 female patients with an orthotopic bladder substitute was observed [5] .
Erectile function Schoenberg et al. reported a correlation between age and erectile function in nerve-sparing cystectomy in his 10 years experience with 101 male patients: 62% in men 49 years and younger, 47% in men 50-59, 43% in men 60-69, and 20% in men 70-79 years old [44] .
In another recent study [23] with a median follow-up of 32 months, 22.4% of 442 evaluated men reported a wellpreserved erectile function without and 15.4% with medical assistance. In a series of 331 men [42] , a recovery of erectile function was significantly more frequent in younger patients (\65 years) following a nerve-sparing surgical procedure (follow-up: 24 months in another study including 49 men, after a 3 years follow-up, 51% of men age 40-59 years were able to have sexual intercourse).
Quality of life
Heningssohn et al. [46] evaluated quality of life in a cohort of patients subjected to radical cystectomy and orthotopic bladder substitution. The results were matched with those obtained from a non-operated control group. Including 101 consecutive, recurrence-free bladder patients, the subjective global quality of life was comparable within both groups.
Hobisch et al. [47] found that quality of life was preserved to a higher degree with an orthotopic neobladder compared to an ileal conduit urinary diversion in 102 male and female patients with a mean follow-up of 37 months. Other studies comparing different types of urinary diversion (incontinent versus continent versus orthotopic diversion) were unable to confirm a superior quality of life of an orthotopic neobladder substitution. . Distress in patients after cystectomy and continent urinary diversion in general was due to a compromised sexual function, urinary problems, and bowel dysfunction [46] .
Geriatric patients
Similar mortality and complication rates have been demonstrated for elderly patients, defined as older than 75-80 years, compared to younger patients. Chronological age was not a contraindication for radical cystectomy with curative intent, provided a careful patient selection, and a preoperative risk assessment was combined with a nononcological life expectancy exceeding 2 years [51] .
In a retrospective review of 1,054 patients after cystectomy for curative intent and a median follow-up of 10.2 years, Clark et al. [52] found a similar mortality as well as diversion-related complication rate in age groups \60 (n = 309), 60-69 (381), 70-79 (n = 314), and C80 years. The operative mortality rates were 1, 3, 4, and 0% in each group. A lower proportion of patients older than 80 years underwent an orthotopic diversion. Three-and five-year overall survival rates of 60 and 53% in patients aged 70 or older compared to 68 and 63%, respectively, in patients younger than 70 years were seen in this large retrospective study [53] . [56] .
Conclusion
After more than three decades, orthotopic bladder substitution subsequent to radical cystectomy has stood the test of time by providing adequate long-term survival and low local recurrence rates. Compared to radical cystectomy, neither radiation nor chemotherapy, nor a combination of both, offer similar long-term results. Orthotopic bladder substitution does not compromise oncological outcome and on the other hand can be performed with excellent results regarding functional and quality of life issues and should therefore be the diversion of choice both in men and in women. Chronological age is generally not a contraindication for cystectomy. However, for orthotopic urinary diversion, a careful patient selection considering tumor extent, patient motivation, preoperative sphincter function, other local and systemic adverse confounding factors, and overall life expectancy must be taken into account. Minimally invasive techniques are promising concepts for the future, awaiting confirmation in larger patient cohorts.
